The remaining patients were classified as LGG, not otherwise specified (LGG-NOS, n = 236), owing to the lack of information on 1p/19q deletion status, or GBM-NOS (n = 36), owing to the lack of information on IDH1/2 mutation status. Here, IDH1 is linked to glioblastoma.